Correspondence: Dr Morini, Pediatric Ophthalmology Ser- Owing to planned cataract surgery of the right eye, bima- vice, Ospedale Pediatrico Bambino Gesù, Piazza S. Ono- toprost treatment was discontinued; periodic slitlamp ex- frio 4, 00165 Rome, Italy (
[email protected]). aminations showed that the cyst gradually diminished and Financial Disclosure: None reported. finally disappeared within the following 6 weeks. Despite normal configuration of the anterior chamber and iris sur- 1. Gomes JA, Romano A, Santos MS, Dua HS. Amniotic membrane use in oph- thalmology. Curr Opin Ophthalmol. 2005;16(4):233-240. face, repeated ultrasound biomicroscopy revealed a small 2. Pires RT, Tseng SC, Prabhasawat P, et al. Amniotic membrane transplanta- cystic structure persisting close to the junction between the tion for symptomatic bullous keratopathy. Arch Ophthalmol. 1999;117(10): 1291-1297. iris and ciliary body (Figure 2B). 3. Paridaens D, Beekhuis H, van Den Bosh W, Remeyer L, Melles G. Amniotic membrane transplantation in the management of conjunctival malignant mela- Comment. Both latanoprost and bimatoprost are topi- noma and primary acquired melanosis with atypia. Br J Ophthalmol. 2001; 85(6):658-661. cally applied prostaglandin F2␣ analogues that lower in- 4. Goyal R, Jones SM, Espinosa M, Green V, Nischal KK. Amniotic membrane traocular pressure by improving uveoscleral outflow. In transplantation in children with symblepharon and massive pannus. Arch Ophthalmol. 2006;124(10):1435-1440. the reported case, the capability of latanoprost to induce 5. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithe- iris cysts is confirmed by the recurrence of the cyst after lial defects with ulceration.